Clinical and functional significance of a novel ferroptosis‐related prognosis signature in lung adenocarcinoma

Abstract excerpt

Lung cancer remains the most common and fatal type of cancer around the world, and lung adenocarcinoma (LUAD) is the most common subtype.1 Although gene-targeted therapies and immunotherapies have made great advances, most patients still suffer from drug-resistance or insensitivity to current regimens.2 Ferroptosis is a new regulated cell death form defined in 2012,3 recently, its relevance in multiple...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Lipids, and Metabolism
• Share to Ferroptosis and cancer prognosis
• Share to RNA modifications and cancer